We are live on ! Find out more
REUN

Reunion Neuroscience Inc. Common Shares

Delisted

REUN was delisted on the 31st of July, 2023.

27 hedge funds and large institutions have $12.2M invested in Reunion Neuroscience Inc. Common Shares in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less funds holding

Funds holding: 3027 (-3)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

49% less capital invested

Capital invested by funds: $23.9M → $12.2M (-$11.6M)

67% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 12

Holders
27
Holders Change
-3
Holders Change %
-10%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
12
Closed
8
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$72K

REUN Hedge Fund Activity: Q1 2022 in Review

27 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q1 2022, worth a combined $12.2M — down 49% from $23.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of REUN and 5 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 4 added.

The largest buyer was DAFNA Capital Management, adding an estimated $3.08M. The largest seller was Point72 Asset Management, cutting an estimated $1.89M.

  • 27 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q1 2022, down from 30 in Q4 2021.
  • Funds reported $12.2M of Reunion Neuroscience Inc. Common Shares stock for Q1 2022, down 49% quarter-over-quarter.
  • 5 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q1 2022 and 8 closed out, a net change of -3 holders.
  • The largest Reunion Neuroscience Inc. Common Shares buyer in Q1 2022 was DAFNA Capital Management, an estimated $3.08M added.
  • The largest Reunion Neuroscience Inc. Common Shares seller in Q1 2022 was Point72 Asset Management, an estimated $1.89M sold.

Based on aggregated 13F filings for Q1 2022.